A federal judge issued a $35 million settlement for a class action case involving major drug company GlaxoSmithKline's (GSK) product Flonase. The plaintiffs claim GSK blocked the sale of a generic version of the nasal spray by filing false petitions, causing indirect purchasers of the drug to overpay for the spray. Attorneys from Ballard Spahr represented GSK in the case.

Related Practices

Complex Commercial Litigation
Consumer Class Action Litigation